AIM ImmunoTech Inc. (AIM) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

AIM ImmunoTech Inc. (AIM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.4M, listed on AMEX, employing roughly 21 people, carrying a beta of 1.24 to the broader market. AIM ImmunoTech Inc. Led by Thomas K. Equels, public since 1995-11-02.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for AIM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →